Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice

Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterologie a hepatologie 2019-02, Vol.73 (1), p.25-31
Hauptverfasser: Kolář, Martin, Ďuricová, Dana, Bortlík, Martin, Pudilová, Karolína, Hrubá, Veronika, Machková, Naděžda, Mitrová, Katarína, Malíčková, Karin, Lukáš, Martin, Vašátko, Martin, Vaníčková, Radka, Lukáš, Milan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 31
container_issue 1
container_start_page 25
container_title Gastroenterologie a hepatologie
container_volume 73
creator Kolář, Martin
Ďuricová, Dana
Bortlík, Martin
Pudilová, Karolína
Hrubá, Veronika
Machková, Naděžda
Mitrová, Katarína
Malíčková, Karin
Lukáš, Martin
Vašátko, Martin
Vaníčková, Radka
Lukáš, Milan
description
doi_str_mv 10.14735/amgh201925
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_14735_amgh201925</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_14735_amgh201925</sourcerecordid><originalsourceid>FETCH-LOGICAL-c148t-89a4f4c9b22aa86b288b7dea2d35e2561ed68aa5e96dec01223a95e454c9b0743</originalsourceid><addsrcrecordid>eNpFUMtKw0AUHUTBUrvyB2YvqfNMJksJPgoFNyouhHAzc2NG8ygzqVBX_oa_55fY1oKr8-CcsziEnHM25yqT-hK610Ywngt9RCbcMJUYJp-PDzwzmTolsxjfGGNia8mUTcjLE7qh9Z_rDir6Eed0HUd89_1eQ6QR7dC7pPU90rHBAKsN9T0twtD0P1_fkTofESLuTLtNeQstXQWwo7d4Rk5qaCPODjgljzfXD8Vdsry_XRRXy8RyZcbE5KBqZfNKCACTVsKYKnMIwkmNQqccXWoANOapQ8u4EBJyjUrvOixTckou_nZtGGIMWJer4DsIm5Kzcv9N-f-N_AUla1mA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kolář, Martin ; Ďuricová, Dana ; Bortlík, Martin ; Pudilová, Karolína ; Hrubá, Veronika ; Machková, Naděžda ; Mitrová, Katarína ; Malíčková, Karin ; Lukáš, Martin ; Vašátko, Martin ; Vaníčková, Radka ; Lukáš, Milan</creator><creatorcontrib>Kolář, Martin ; Ďuricová, Dana ; Bortlík, Martin ; Pudilová, Karolína ; Hrubá, Veronika ; Machková, Naděžda ; Mitrová, Katarína ; Malíčková, Karin ; Lukáš, Martin ; Vašátko, Martin ; Vaníčková, Radka ; Lukáš, Milan</creatorcontrib><identifier>ISSN: 1804-7874</identifier><identifier>EISSN: 1804-803X</identifier><identifier>DOI: 10.14735/amgh201925</identifier><language>eng</language><ispartof>Gastroenterologie a hepatologie, 2019-02, Vol.73 (1), p.25-31</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c148t-89a4f4c9b22aa86b288b7dea2d35e2561ed68aa5e96dec01223a95e454c9b0743</citedby><orcidid>0000-0001-9501-0604</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Kolář, Martin</creatorcontrib><creatorcontrib>Ďuricová, Dana</creatorcontrib><creatorcontrib>Bortlík, Martin</creatorcontrib><creatorcontrib>Pudilová, Karolína</creatorcontrib><creatorcontrib>Hrubá, Veronika</creatorcontrib><creatorcontrib>Machková, Naděžda</creatorcontrib><creatorcontrib>Mitrová, Katarína</creatorcontrib><creatorcontrib>Malíčková, Karin</creatorcontrib><creatorcontrib>Lukáš, Martin</creatorcontrib><creatorcontrib>Vašátko, Martin</creatorcontrib><creatorcontrib>Vaníčková, Radka</creatorcontrib><creatorcontrib>Lukáš, Milan</creatorcontrib><title>Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice</title><title>Gastroenterologie a hepatologie</title><issn>1804-7874</issn><issn>1804-803X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpFUMtKw0AUHUTBUrvyB2YvqfNMJksJPgoFNyouhHAzc2NG8ygzqVBX_oa_55fY1oKr8-CcsziEnHM25yqT-hK610Ywngt9RCbcMJUYJp-PDzwzmTolsxjfGGNia8mUTcjLE7qh9Z_rDir6Eed0HUd89_1eQ6QR7dC7pPU90rHBAKsN9T0twtD0P1_fkTofESLuTLtNeQstXQWwo7d4Rk5qaCPODjgljzfXD8Vdsry_XRRXy8RyZcbE5KBqZfNKCACTVsKYKnMIwkmNQqccXWoANOapQ8u4EBJyjUrvOixTckou_nZtGGIMWJer4DsIm5Kzcv9N-f-N_AUla1mA</recordid><startdate>20190228</startdate><enddate>20190228</enddate><creator>Kolář, Martin</creator><creator>Ďuricová, Dana</creator><creator>Bortlík, Martin</creator><creator>Pudilová, Karolína</creator><creator>Hrubá, Veronika</creator><creator>Machková, Naděžda</creator><creator>Mitrová, Katarína</creator><creator>Malíčková, Karin</creator><creator>Lukáš, Martin</creator><creator>Vašátko, Martin</creator><creator>Vaníčková, Radka</creator><creator>Lukáš, Milan</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0001-9501-0604</orcidid></search><sort><creationdate>20190228</creationdate><title>Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice</title><author>Kolář, Martin ; Ďuricová, Dana ; Bortlík, Martin ; Pudilová, Karolína ; Hrubá, Veronika ; Machková, Naděžda ; Mitrová, Katarína ; Malíčková, Karin ; Lukáš, Martin ; Vašátko, Martin ; Vaníčková, Radka ; Lukáš, Milan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c148t-89a4f4c9b22aa86b288b7dea2d35e2561ed68aa5e96dec01223a95e454c9b0743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kolář, Martin</creatorcontrib><creatorcontrib>Ďuricová, Dana</creatorcontrib><creatorcontrib>Bortlík, Martin</creatorcontrib><creatorcontrib>Pudilová, Karolína</creatorcontrib><creatorcontrib>Hrubá, Veronika</creatorcontrib><creatorcontrib>Machková, Naděžda</creatorcontrib><creatorcontrib>Mitrová, Katarína</creatorcontrib><creatorcontrib>Malíčková, Karin</creatorcontrib><creatorcontrib>Lukáš, Martin</creatorcontrib><creatorcontrib>Vašátko, Martin</creatorcontrib><creatorcontrib>Vaníčková, Radka</creatorcontrib><creatorcontrib>Lukáš, Milan</creatorcontrib><collection>CrossRef</collection><jtitle>Gastroenterologie a hepatologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kolář, Martin</au><au>Ďuricová, Dana</au><au>Bortlík, Martin</au><au>Pudilová, Karolína</au><au>Hrubá, Veronika</au><au>Machková, Naděžda</au><au>Mitrová, Katarína</au><au>Malíčková, Karin</au><au>Lukáš, Martin</au><au>Vašátko, Martin</au><au>Vaníčková, Radka</au><au>Lukáš, Milan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice</atitle><jtitle>Gastroenterologie a hepatologie</jtitle><date>2019-02-28</date><risdate>2019</risdate><volume>73</volume><issue>1</issue><spage>25</spage><epage>31</epage><pages>25-31</pages><issn>1804-7874</issn><eissn>1804-803X</eissn><doi>10.14735/amgh201925</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-9501-0604</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1804-7874
ispartof Gastroenterologie a hepatologie, 2019-02, Vol.73 (1), p.25-31
issn 1804-7874
1804-803X
language eng
recordid cdi_crossref_primary_10_14735_amgh201925
source EZB-FREE-00999 freely available EZB journals
title Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T20%3A47%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vedolizumab%20vs.%20ustekinumab%20as%20second-line%20therapy%20in%20Crohn%E2%80%99s%20disease%20in%20clinical%20practice&rft.jtitle=Gastroenterologie%20a%20hepatologie&rft.au=Kol%C3%A1%C5%99,%20Martin&rft.date=2019-02-28&rft.volume=73&rft.issue=1&rft.spage=25&rft.epage=31&rft.pages=25-31&rft.issn=1804-7874&rft.eissn=1804-803X&rft_id=info:doi/10.14735/amgh201925&rft_dat=%3Ccrossref%3E10_14735_amgh201925%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true